Clinical Trial Update: Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the pharmacokinetics and safety of HCP1303 alone and in combination with HGP1201 and HIP1402 in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction

Drugs mentioned

• HCP1303
• HGP1201
• HIP1402

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Erectile Dysfunction, Prostatic Hyperplasia | Phase 1 | Status: COMPLETED